Share on LinkedInShare on LinkedIn

ARTICLE · 10 FEBRUARY 2022

Competition Law In The Pharma Sector – Developments And What's To Come In 2022

In this update, our pharma sector competition law experts in Brussels, the UK, Germany, South Africa and China look at a number of recent competition law developments of impact to the sector.

GlobalAntitrust/Competition Law

In this update, our pharma sector competition law experts in Brussels, the UK, Germany, South Africa and China look at a number of recent competition law developments of impact to the sector. This is a selective list of developments that have practical implications on the way pharma companies do business.

European Union

The pharma sector has long been a focus of the enforcement activity for the European Commission. As a former EU Commissioner put it the sector is "literally essential" for European citizens' lives.
Over the past few months the Commission has reaffirmed its aim to ensure innovation and competition in the sector. 2022 promises to bring important developments, across a number of fronts:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from